MIRA INFORM REPORT

 

 

Report Date :

10.10.2013

 

IDENTIFICATION DETAILS

 

Name :

GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED

 

 

Registered Office :

Patiala Road, Nabha, District Patiala – 147201, Punjab

 

 

Country :

India

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

30.10.1958

 

 

Com. Reg. No.:

16-002257

 

 

Capital Investment / Paid-up Capital :

Rs. 420.555 Millions

 

 

CIN No.:

[Company Identification No.]

L24231PB1958PLC002257

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

PTLG11719B

 

 

Legal Form :

A Public Limited Liability Company. The Company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Manufacturer of Malt based Food, Protein Rich Food, Cereal Beverages, Nutritional Food Powder, etc.

 

 

No. of Employees :

3463 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (64)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

 

Maximum Credit Limit :

USD 54000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

GlaxoSmithKline Consumer Healthcare Limited (GSKCH) is an Indian Associate of GlaxoSmithKline Plc. U.K.

 

It is a well-established and reputed company having fine track record.

 

Financial position of the company is good. Networth of the company appears to be strong and healthy. Profit margin of the company reported to be fair.

 

Trade relations are reported as fair. Business is active. Payments are reported to be regular and as per commitments.

 

The company can be considered good for business dealings at usual trade terms and conditions.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

We are living in a world where volatility and uncertainty have become the New Normal. We saw a change of government in countries like Tunisia, Egypt, Libya and Vietnam. Once powerful countries in Europe are now fighting for bankruptcy. We have taken growth in the developing part of the world for granted but economic growth in China and India has begun to slow. Companies that were synonymous with their product categories just a few years ago are now no longer in existence. Kodak, the inventor of the digital camera had to wind up its operations, HMV, the British entertainment retailing company and Borders, once the second largest bookstore have shut down due to their inability to evolve their business models with the changing time. Readers’ Digest, Thomson Register are no more !

 

There is another megatrend happening. The World order is changing as economic power shifts from West to East. According to McKinsey study, it took Britain more than 100 years to double its economic output per person during its industrial revolution and the US later took more than 50 years to do the same. More than a century later, China and India have doubled their GDP per capital in 12 and 18 years respectively. By 2020, emerging Asia will become the world’s largest consuming block, overtaking North America.

 

The years after the outbreak of the global financial crisis, the world economy continues to remain fragile. The Indian economy demonstrated remarkable resilience in the initial years of the contagion but finally lost ground last year. GDP growth slowed down. Currency has been weakening. There is a marked deceleration in agriculture, industry and services. Dampening sentiment led to a cut-back in investment as well as private consumption expenditure.  Inflation remained at high levels fuelled by the pressure from the food and fuel sectors. The large fiscal and current account deficit s continued to cause grave concern. It is imperative that India regains its growth trajectory of 8-9 % sooner than later. This is crucially important given the need to create gainful livelihood opportunities for the millions living in poverty as also the large contingent of young people joining the job market every year.

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION DECLINED

 

MANAGEMENT NON-COOPERATIVE [91-124-2540700]

 

 

LOCATIONS

 

Registered Office/ Factory 1 :

Patiala Road, Nabha, District Patiala – 147201, Punjab, India

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

investor.2.co@gsk.com

Website :

http://www.gsk-ch.in

 

 

Head/ Corporate  Office :

DLF Plaza Tower, DLF Phase I, Gurgaon – 122002, Haryana, India

Tel. No.:

91-124-2540700/ 5057700

Fax No.:

91-124-2540720/ 2540721

E-Mail :

contact.4.gsk@gsk.com

 

 

Factory 2 :

Industrial Area, Dowleswaram – 533124, Andhra Pradesh, India

 

 

Factory 3 :

14 km Stone, Sonepat - Meerut Road, Village Khewra, P.O. Bahalgarh, District Sonepat -130121, Haryana, India

 

 

Regional Offices :

Located at:

 

­  New Delhi

­  Kolkata

­  Mumbai

­  Chennai

 

 

Depots :

Located at:

 

South

­  Bangalore

­  Chennai

­  Cochin

­  Pondicherry

­  Kandlakoya (Hyderabad)

­  Madurai

 

East

­  Cuttack

­  Guwahati

­  Ranchi

­  Dankuni (Kolkata)

­  Patna

­  Siliguri

 

West

­  Ahmedabad

­  Goa

­  Indore

­  Pune

­  Raipur

 

North

­  Dehradun

­  Jaipur

­  Delhi

­  Lucknow

­  Panchkula

­  Zirakpur

 

 

RDCs :

Located at:

 

­  Kandlakoya (Hyderabad)

­  Ambala

­  Delhi

 

 

DIRECTORS

 

AS ON 31.12.2012

 

Name :

Mr. Simon J. Scarff, O.B.E

Designation :

Chairman

 

 

Name :

Mr. Zubair Ahmed

Designation :

Managing Director

 

 

Name :

Mr. Kunal Kashyap

Designation :

Director

 

 

Name :

Mr. Mukesh H. Butani

Designation :

Director

 

 

Name :

Mr. Naresh Dayal

Designation :

Director

 

 

Name :

P. Dwarakanath

Designation :

Director

 

 

Name :

Mr. Praveen K. Gupta (till 31.01.2012)

Designation :

Director

 

 

Name :

Jaiboy J. Phillips (w.e.f.06.02.2012)

Designation :

Director

 

 

Name :

Mr. Ramakrishnan Subramanian

Designation :

Director

 

 

Name :

Mr. Subodh Bhargava

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. Surinder Kumar

Designation :

Company Secretary

 

 

Name :

Ms. Sonali Khanna

Designation :

General Manager - Legal

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 30.06.2013

 

Category of Shareholder

Total No. of Shares

As a %

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

30471992

72.46

http://www.bseindia.com/include/images/clear.gifSub Total

30471992

72.46

Total shareholding of Promoter and Promoter Group (A)

30471992

72.46

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

26720

0.06

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

200403

0.48

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

4965396

11.81

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

280

0.00

http://www.bseindia.com/include/images/clear.gifForeign Companies

280

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

5192799

12.35

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

816831

1.94

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 Million

4196230

9.98

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 Million

1277042

3.04

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

100644

0.24

http://www.bseindia.com/include/images/clear.gifTrusts

951

0.00

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

77883

0.19

http://www.bseindia.com/include/images/clear.gifClearing Members

21810

0.05

http://www.bseindia.com/include/images/clear.gifSub Total

6390747

15.20

Total Public shareholding (B)

11583546

27.54

Total (A)+(B)

42055538

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

 

 

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

0

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

0

0.00

Total (A)+(B)+(C)

42055538

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Malt based Food, Protein Rich Food, Cereal Beverages, Nutritional Food Powder, etc.

 

 

Products/ Services :

ITC Code No.

 

Product Descriptions

19019090

Malt Based Foods

19019090

Protein Rich Food

19019090

Cereal Based Beverage

21069099

Nutritional Food Powder

 

 

PRODUCTION STATUS (AS ON 31.03.2011)

 

Particulars

Licensed Capacity Qty MT

Installed Capacity Qty MT

Actual Production* Qty MT

1. Malt Based Foods

105000

37689

2. Cereal Based Beverage

2000

114400

3414

3. Powdered Milk

3000

--

4. Protein Rich Foods

3000

1200

960

5. Nutritional Food Powder

1200

 

56

6. Malt Based Foods

--

--

78982

7. Protein Rich Foods

--

--

516

8. Cereal Based Beverage

--

--

342

Total

114200

115600

121959

9. Ghee

6000

4000

371

10. Packaged Foods

--

--

638

 

* Actual Production includes Bulk Production and does not include Trial Production

 

Notes:

 

1.     The actual production under Serial No. 1 does not include production of intermediate products of 48,280 MT (Previous Year 43,081 MT) for captive consumption. This intermediate product is further processed at Third Party for manufacture of Malt Based Foods and accordingly, the said production is disclosed under Serial No. 6. Further, the closing stock under Serial No. 1 does not include 5,586 MT amounting to Rs. 600.119 Millions (Previous year 5,100 MT amounting to Rs. 511.883 Millions)

 

2.     The installed capacities on triple shift basis are as per certificates given by the Director-Operations and have not been verified by the Auditors, being a technical matter.

 

3.     Production figures are net of captive consumption.

 

4.     Powdered Milk is for captive consumption and accordingly the same have been included in Goods in Process in Schedule 5 and 15. Boost Intermediate/ Horlicks Intermediates are included in Goods in Process in Schedule 5 and 15 as these are semi-finished products.

 

5.     Licensed capacity listed above Serial No. 1, 2, 3, 4, 5 and 9 are in respect to all the three factories of the company and are covered by Industrial Entrepreneurs' Memorandums (IEMs) in terms of Notification No. 477 (E) dated July 25, 1991 of the Department of Industrial Development, Ministry of Industry, Government of India.

 

6.     The Products under Serial No. 1, 2 and 3 to 5 are manufactured in an integrated plant respectively and, therefore, installed capacity cannot be given separately.

 

7.     The Products listed under Serial No. 6, 7, 8 and 10 are processed by Third Parties.

 

8.     Closing Stock is net of samples, internal consumption, other stock losses

 

 

GENERAL INFORMATION

 

No. of Employees :

3463 (Approximately)

 

 

Bankers :

­  Deutsche Bank

­  Citibank N.A.

­  BNP Paribas

­  State Bank of India

­  HDFC Bank Limited

­  The Hongkong and Shanghai Banking Corporation Limited

­  Dena Bank

­  ICICI Bank Limited

­  State Bank of Patiala

­  Andhra Bank

­  JP Morgan Chase Bank N.A.

 

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Price Waterhouse

Chartered Accountants

 

 

Promoter Company :

Horlicks Limited, (a subsidiary of GlaxoSmithKline Plc UK) holds 43.16% of equity shares of the Company.

 

 

Other related parties in GlaxoSmithKline Group which are under Common Control :

­  Glaxo Operations UK Area

­  Glaxo SmithKline Bangladesh Limited

­  Glaxo SmithKline Exports Limited

­  Glaxo Wellcome Indonesia

­  GlaxoSmithKline Asia Private Limited

­  GlaxoSmithKline Australia Pty

­  GlaxoSmithKline Consumer Healthcare GmbH

­  GlaxoSmithKline Consumer Healthcare Kenya

­  GlaxoSmithKline Consumer Healthcare SDN BHD Malaysia

­  GlaxoSmithKline Pharmaceuticals Limited

­  GlaxoSmithKline Philippines Inc.

­  GlaxoSmithKline Pte. Limited

­  GlaxoSmithKline Services Unlimited (U.K.)

­  GlaxoSmithKline Trading Services Limited

­  GSK Nigeria

­  GSK Plc, UK

­  GSK Services Limited

­  S B Bangladesh

­  PT Sterling Products Indonesia

­  SB Corp CB (USA)

­  SB Pharmaceutical Services

­  SB Research Limited

­  SB Corporate Centre

­  SmithKline Beecham (Private) Limited, Sri Lanka

­  SmithKline Beecham Corporation

­  Sterling Drugs (M) Sdn Bhd

­  Tianjin SmithKline and French Labs Limited, China

­  GSK China Investment Company Limited

­  Glaxo Wellcome Manufacturing Pte Limited

­  GSK South Africa Pty

­  Glaxo Saudi Arabia Limited

­  GlaxoSmithKline Pakistan Limited

­  Glaxo Opearation UK Limited

 

 

Trusts under Control of the Board of the Trustees :

­  Senior Staff Gratuity Fund

­  Employees’ Gratuity Fund

­  Provident Fund

­  Indian Senior Executives Superannuation Fund

 

 

CAPITAL STRUCTURE

 

AS ON 31.12.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

60000000

Equity Shares

Rs. 10/- each

Rs. 600.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

42055538

Equity Shares

Rs. 10/- each

Rs. 420.555 Millions

 

 

 

 

 

 

(A) Shares held by Ultimate Holding Company and its Subsidiaries

 

18152243 (previous year: 18152243) Equity Shares are held by Horlicks Limited, a subsidiary of GlaxoSmithKline Plc UK, the Ultimate Holding Company

 

(B) Reconciliation of Equity Shares outstanding

 

Particulars

 

31.12.2012

 

No. of Shares

Rs. in Millions

Balance at the beginning of the year

42055538

420.555

Add : Shares issued during the year

--

--

Less : Shares bought back during the year

--

--

Balance at the end of the year

42055538

420.555

 

 

(C) Details of shareholders having more than 5% of the aggregate shares in the Company

 

Name of Shareholder

31.12.2012

 

 

No. of Shares held

Rs. in Millions

Horlicks Limited

18152243

43.16%

Arisaig Partners (Asia) Pte Limited A/c Arisaig India

2106101

5.01%

 

D) Rights, preferences and restrictions attached to shares

 

The Company has one class of equity shares having a par value of Rs. 10 per share. Each shareholder is eligible for one vote per share held.


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

 

31.12.2012

31.12.2011

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

 

420.555

420.555

(b) Reserves & Surplus

 

13189.219

11021.171

(c) Money received against share warrants

 

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

 

0.000

0.000

Total Shareholders’ Funds (1) + (2)

 

13609.774

11441.726

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

 

0.000

0.000

(b) Deferred tax liabilities (Net)

 

0.000

0.000

(c) Other long term liabilities

 

114.831

99.668

(d) long-term provisions

 

767.968

507.597

Total Non-current Liabilities (3)

 

882.799

607.265

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

 

0.000

0.000

(b) Trade payables

 

4784.375

3593.686

(c) Other current liabilities

 

3514.892

2942.658

(d) Short-term provisions

 

2753.079

2239.232

Total Current Liabilities (4)

 

11052.346

8775.576

 

 

 

 

TOTAL

 

25544.919

20824.567

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

 

1938.323

2006.894

(ii) Intangible Assets

 

0.000

0.000

(iii) Capital work-in-progress

 

1972.386

1491.579

(iv) Intangible assets under development

 

0.000

0.000

(b) Non-current Investments

 

0.000

0.000

(c) Deferred tax assets (net)

 

616.263

398.897

(d)  Long-term Loan and Advances

 

446.638

504.276

(e) Other Non-current assets

 

0.000

0.000

Total Non-Current Assets

 

4973.610

4401.646

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

 

0.000

0.000

(b) Inventories

 

3696.355

3699.558

(c) Trade receivables

 

1126.144

991.907

(d) Cash and cash equivalents

 

14642.426

10796.544

(e) Short-term loans and advances

 

668.058

600.328

(f) Other current assets

 

438.326

334.584

Total Current Assets

 

20571.309

16422.921

 

 

 

 

TOTAL

 

25544.919

20824.567

 

 

SOURCES OF FUNDS

 

 

 

31.12.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

 

 

420.555

2] Share Application Money

 

 

0.000

3] Reserves & Surplus

 

 

9179.832

4] (Accumulated Losses)

 

 

0.000

NETWORTH

 

 

9600.387

LOAN FUNDS

 

 

 

1] Secured Loans

 

 

0.000

2] Unsecured Loans

 

 

0.000

TOTAL BORROWING

 

 

0.000

DEFERRED TAX LIABILITIES

 

 

0.000

 

 

 

 

TOTAL

 

 

9600.387

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

 

 

2022.520

Capital work-in-progress

 

 

1083.262

 

 

 

 

INVESTMENT

 

 

0.005

DEFERRED TAX ASSETS

 

 

267.346

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

 

 

3120.006

 

Sundry Debtors

 

 

503.664

 

Cash & Bank Balances

 

 

9760.983

 

Other Current Assets

 

 

345.566

 

Loans & Advances

 

 

501.073

Total Current Assets

 

 

14231.292

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

 

 

3569.246

 

Other Current Liabilities

 

 

1134.427

 

Provisions

 

 

3300.365

Total Current Liabilities

 

 

8004.038

Net Current Assets

 

 

6227.254

 

 

 

 

MISCELLANEOUS EXPENSES

 

 

0.000

 

 

 

 

TOTAL

 

 

9600.387

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.12.2012

 

31.12.2011

31.12.2010

 

SALES

 

 

 

 

 

Revenue from operations (Net)

31874.936

27650.045

23061.183

 

 

Other Income

1137.858

852.521

1173.928

 

 

TOTAL                                     (A)

33012.794

28502.566

24235.111

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of materials consumed

10198.918

9297.390

 

 

 

Purchases of stock-in-trade

1464.299

1343.298

 

 

 

Changes in inventories of finished goods, work-in-progress and stock-in-trade

(144.747)

(440.007)

 

 

 

Employee benefits expense

3011.195

2583.656

 

 

 

Other expenses

11611.174

9821.196

 

 

 

TOTAL                                     (B)

26140.840

22605.530

19319.972

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

6871.955

5897.033

4915.139

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

24.233

34.664

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

6847.722

5862.369

4915.139

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

360.837

459.756

397.094

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                              (G)

6486.885

5402.613

4518.045

 

 

 

 

 

Less

TAX                                                                  (H)

2119.327

1850.544

1519.521

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

4367.558

3552.069

2998.524

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

2945.099

1458.967

1209.393

 

 

 

 

 

 

ADJUSTMENT OF DIFFERENTIAL DIVIDEND TAX FOR PRIOR YEAR

0.000

0.000

2.924

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Proposed Dividend - Final

1892.499

1471.944

2102.777

 

 

Corporate Dividend Tax

307.011

238.786

349.245

 

 

Transferred to General Reserve

436.756

355.207

299.852

 

BALANCE CARRIED TO THE B/S

4676.391

2945.099

1458.967

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export of goods on F.O.B. basis

1914.694

1815.921

1333.175

 

 

Miscellaneous Income

63.242

31.933

11.941

 

TOTAL EARNINGS

1977.936

1847.854

1345.116

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

216.441

133.807

135.205

 

 

Capital Goods

37.044

70.063

162.391

 

TOTAL IMPORTS

253.485

203.870

297.596

 

 

 

 

 

 

Earnings Per Share (Rs.)

103.85

84.46

71.30

 

 

QUARTERLY RESULTS

 

PARTICULARS

 

 

31.03.2013

30.06.2013

Type

 

1st Quarter

2nd Quarter

 Sales Turnover

 

9753.800

8903.000

 Total Expenditure

 

7690.800

7342.600

 PBIDT (Excl OI)

 

2063.000

1560.400

 Other Income

 

324.400

385.300

 Operating Profit

 

2387.400

1945.700

 Interest

 

1.400

1.600

 Exceptional Items

 

0.000

0.000

 PBDT

 

2386.000

1944.100

 Depreciation

 

107.000

122.000

 Profit Before Tax

 

2279.000

1822.100

 Tax

 

714.900

622.500

Provisions and Contingencies

 

0.000

0.000

 Reported PAT

 

1564.100

1199.600

Extraordinary Items      

 

0.000

0.000

Prior Period Expenses

 

0.000

0.000

Other Adjustments

 

0.000

0.000

Net Profit

 

1564.100

1199.600

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.12.2012

 

31.12.2011

31.12.2010

PAT / Total Income

(%)

13.23

12.46

12.37

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

20.35

19.54

19.59

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

28.26

28.53

27.80

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.48

0.47

0.47

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.00

0.00

0.00

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.86

1.87

1.78

 

 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

(Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

No

8]

No. of employees

Yes

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR COMPANY

 

 

PERFORMANCE OF THE COMPANY

 

This is a landmark year for the Company having crossed three key milestones, Rs. 30000.000 Millions sales, Rs. 3,000 share price and Rs. 100 EPS. The company recorded 15% increase in sales and 23% increase in PAT during 2012 over the previous year. The Company has now achieved consistent double digit profitable growth for the eighth year in a row.

 

The strong double digit performance of the Company’s key brands – Horlicks and Boost continued during 2012. Horlicks registered a growth of 15.3% with strong performance across variants. The Mega Brand Horlicks witnessed a re-launch during the year on the platform of a strong scientific claim, whereby Horlicks is clinically proven to “Improve the 5 Signs of Growth” supplementing the existing claim of Taller, Stronger and Sharper. The re-launch was supported by a strong Media campaign, which turned out to be one of the most high-decibel and impactful launches in the FMCG sector this year. The on-ground execution also kept pace with some never before visibility in trade, practically owning the stores across markets and partnering with 10,000+ doctors across the Country. The Horlicks extensions range continues to grow from strength to strength. After the successful campaign in North-West on Power of Milk, Horlicks launched the next big initiative in North-West, “The Tastiest Chocolate Horlicks Ever”. The campaign strengthened the “Horlicks increases the Power of Milk” proposition along with the taste credentials of “MORE CHOCOLATY” and helped the Company gain firm ground in the traditionally un-penetrated North and West regions, taking the growth trajectory for these regions to the next level.

 

Boost, which from inception has stood for ‘energy’ at its core, had a momentous year during 2012 with one of the strongest performance recording 19.3% growth. The strong performance of Boost was supported by some innovative campaigns during the year. E.g. “Sachin Tendulkar’s 23 years of Stamina, powered by Boost”, leveraging of the global tie-up between GSK and McLaren in India through which, the Company provided access of the world of F1, to Boosts’ customers and the Boost Anthem (created by Dhanush of “Kolaveri Di” fame), through which Boost made a strong entry into the digital marketing space. The year also witnessed the launch of Boost in an exciting flavour, Boost Choco Éclair, which has performed exceedingly well and connected well with kids on taste.

 

The Foods portfolio continued to deliver strong double digit growth. The biscuits portfolio recorded growth of 26% over 2011. The year also witnessed the foray of brand Horlicks into the Health Biscuits segment with the launch of Nutribic in 2 variants, Fiber Rich Digestive and Zero Added Sugar. The feedback from the market has been very encouraging and within the first quarter of launch, the Company has gained an impressive market share. Horlicks Oats, which was launched in South India last year, has been very well accepted and has garnered an impressive market share ranking third within a short span of time.

 

The Company’s focused cost management and working capital optimisation program continued to deliver strong results in containing inflation and supporting profitable growth. Sustained improvement in working capital continued in 2012. The cost optimization programs and returns from surplus cash arising from working capital initiatives have supported sustained investments in the Company’s brands. 2012 witnessed several strong impactful campaigns which have been covered above.

 

The Company has successfully completed a major capacity expansion project in February 2013. The project involved commissioning of a new manufacturing line using Vacuum Band Drier (VBD) technology, which involves extensive automation and controls. This is the World’s largest Vacuum Band Dryer line and will augment their capacity by 18 thousand tones p.a.

 

 

RESERVES

 

The total Reserves as on December 31, 2012 stood at Rs. 13189.223 Millions representing an increase of 19.7% from last year.

 

 

INFORMATION TECHNOLOGY

 

The Company continues to be at the forefront of Information Technology. The Information Technology function has played the crucial role of a business enabler having effectively partnered with all functions. During the year, the Company has initiated projects with cutting edge technology to strengthen the Sales force effectiveness.

 

The Information Technology has displayed excellent agility and provided innovative solutions to address changing business requirements.

 

 

MANAGEMENT DISCUSSION AND ANALYSIS REPORT

 

INDUSTRY STRUCTURE AND DEVELOPMENT

 

The tough economic conditions of 2011 continued in 2012. While inflation did begin to taper off from the highs of 2011, the expectations of a rate cut continued to elude the market all through 2012. The high interest rates coupled with a lackluster reforms process slowed down the industrial production. This coupled with the subdued performance in both services and agriculture, has significantly slowed down the GDP growth in the current fiscal and is expected to be the lowest in a decade. Amidst the gloomy scenario, the second half of 2012 saw some serious reform making process and political will in making efforts to bring the economy back to track. Some tough economic measures namely FDI in Retail, Oil and Gas and Power sector reforms, which saw the light of the day in the second half of 2012, brought about a welcome change. FII inflows in 2012 @ USD 23.2 Billion were the second highest in the last decade and to end with, 2012 turned out to be a fantastic year for the stock markets.

 

While the economic challenges continue, they move into 2013 with a renewed sense of confidence on most fronts. Clearly, the undertone in the markets is that the worst is over. Positive Government action the reforms process is extremely encouraging. Further, inflation is expected to tone down in 2013 and pave the way for reduction in interest rates in a phased manner by over 100 basis points. These factors are collectively expected to end the slump in factory output. With a normal monsoon in 2013, GDP growth is expected to gradually improve to 6-7%.

 

 

OPPORTUNITIES, THREATS AND OUTLOOK

 

The slowdown in economy did have an adverse impact on the private consumption and the FMCG sector as a whole. A strong rebound in growth seems unlikely in the near short term. Further, the twin deficits are currently at unsustainably high levels and any significant fiscal corrective action from the Government will result in further dampening the economy. While the Government has pledged to go strong on the reforms process, some of the actions, particularly the deregulation of oil prices and SEB reforms will add to inflationary pressures. Prices of key commodities to their business which have been largely under control during 2012 will be closely watched given their sensitivity to their business. With 2013 being a pre-election year, the pressure on fiscal deficit is likely to continue. However, various social welfare programmes, particularly in the traditionally underpenetrated rural areas will be a key positive to the Consumer goods sector.

 

While they tread carefully amidst various external challenges, the Company strongly believes that they are strategically placed to benefit from the potential offered by the FMCG Sector given their internal strengths on people, processes, business strategy and strong brands with innovation capabilities.

 

 

UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND SIX MONTHS ENDED JUNE 30, 2013

[Rs. in Millions]

 

PART I

 

 

 

 

PARTICULARS

3 Months Ended 30/06/2013

Preceding 3 Months Ended

31/03/2013

Year to date figures for current period ended

30/06/2013

 

 

UNAUDITED

UNAUDITED

UNAUDITED

 

Income from Operations

 

 

 

1

(a) Net Sales / Income from Operations (Net of Excise Duty)

8529.200

9398.600

17927.800

 

(b) Other Operating Income

373.800

355.200

729.000

 

Total Income from operations (Net)

8903.000

9753.800

18656.800

2

Expenses

 

 

 

 

(a) Cost of material consumed

2811.000

2785.500

5596.500

 

(b) Purchase of stock-in-Trade

357.000

392.800

749.800

 

(c) Change of inventories of finished goods, work-in-progress and stock-in-trade

(181.700)

380.900

199.200

 

(d) Employee benefits expense

1044.100

889.500

1933.600

 

(e) Advertising and Promotion

1375.600

1592.900

2968.500

 

(f) Depreciation and Amortisation expense

122.000

107.000

229.000

 

(g) Other Expenses

1936.600

1649.200

3585.800

 

Total Expenses

7464.600

7797.800

15262.400

3

Profit from operations before other income, finance costs and exceptional Items (1-2)

1438.400

1956.000

3394.400

4

Other income

385.300

324.400

709.700

5

Profit from Ordinary activities before finance costs and exceptional Items (3+4)

1823.700

2280.400

4104.100

6

Finance costs

1.600

1.400

3.000

7

Profit from ordinary activities after finance costs but before exceptional items (5-6)

1822.100

2279.000

4101.100

8

Exceptional items

-

-

-

9

Profit from ordinary activities before tax (7+8)

1822.100

2279.000

4101.100

10

Tax expense

622.500

714.900

1337.400

11

Net Profit from ordinary activities after tax (9-10)

1199.600

1564.100

2763.700

12

Extraordinary items (net of tax expense)

-

-

-

13

Net Profit for the period (11-12)

1199.600

1564.100

2763.700

14

Paid Up equity share capital

420.600

420.600

420.600

 

(Face Value of Equity Shares)

10

10

10

15

Reserve excluding Revaluation Reserve as per Balance Sheet of the previous accounting year

 

 

 

16. i

Earnings per share (before extraordinary items) (of Rs 10/- each) (not annualised):

 

 

 

 

(a) Basic and

28.52

37.19

65.71

 

(b) Diluted

 

 

 

16. ii

Earnings per share (after extraordinary items) (of Rs 10/- each) (not annualised):

 

 

 

 

(a) Basic and

28.52

37.19

65.71

 

(b) Diluted

 

 

 

 

PART II

 

 

 

A. PARTICULARS OF SHAREHOLDING

3 Months Ended 30/06/2013

Preceding 3 Months Ended

31/03/2013

Year to date figures for current period ended

30/06/2013

1. Public Shareholding

-Number of Shares

-Percentage of Shareholding

 

11583546

27.54

 

11583546 27.54

 

11583546 27.54

2. Promoters and Promoter Group Shareholding

a)         Pledged/Encumbered

-           Number of shares

-           Percentage of shares (as a % of the total shareholding of Promoter and Promoter Group)

-           Percentage of shares (as a% of the total share capital of the Company)

 

b)         Non-encumbered

-           Number of shares

-           Percentage of shares (as a % of the total shareholding of Promoter and Promoter Group)

-           Percentage of shares (as a% of the total share capital of the Company)

 

 

--

 

--

 

--

 

 

30471992

 

100.00

 

72.46

 

 

--

 

--

 

--

 

 

30471992

 

100.00

 

72.46

 

 

--

 

--

 

--

 

 

30471992

 

100.00

 

72.46

 

 

 

Particulars

3 months ended 30th June 13

B

Investor complaints (Nos.)

 

 

Pending at the beginning of the quarter

Nil

 

Received during the quarter

57

 

Disposed of during the quarter

57

 

Remaining unresolved at the end of the quarter

Nil

 

 

STANDALONE STATEMENT OF ASSETS AND LIABILITIES

 

[Rs. in Millions]

Particulars

As at (Current half year end)

 

(30.06.2013)

A. EQUITY AND LIABILITIES

 

Shareholders' funds

 

a) Share capital

420.600

b) Reserves and surplus

15938.400

Sub-total - Shareholders' funds

16359.000

2. Non-current liabilities

 

a) Long term borrowings

-

b) Deferred tax liabilities (net)

-

c) Other long term liabilities

103.900

d) Long term provisions

1126.500

Sub-total - Non-current liabilities

1230.400

3. Current liabilities

 

a) Short-term borrowings

-

b) Trade payables

5455.700

c) Other current liabilities

4686.600

d) Short-term provisions

861.600

Sub-total - Current liabilities

11003.900

 

 

TOTAL - EQUITY AND LIABILITIES

 

28593.300

 

 

B. ASSETS

 

1. Non-current Assets

 

a) Fixed assets #

3810.400

b) Deferred tax assets (net)

694.300

c) Long-term loans & advances

1775.800

d) Other non-current assets

-

Sub-total - Non-current assets

6280.500

2. Current Assets

 

a) Inventories

3585.800

b) Trade receivables

2622.200

c) Cash and cash equivalents

14401.500

d) Short term loans and advances

837.600

e) Other current assets

865.700

Sub-total - Current assets

22312.800

 

 

TOTAL – ASSETS

 

28593.300

 

# Fixed Assets includes CWIP aggregating Rs 320.027 Millions as at June 30, 2013 (Rs 1972.386 Millions as at Dec 31, 2012)

 

Notes:

 

1.     The Company's nutritional business is India focused and in a single business and geographical segment. Accordingly segment information is not applicable.

2.     The Company received 57 investor complaints during the quarter ended June 30, 2013 which were duly resolved by the end of the quarter. There were no investor complaints pending at the beginning and at the end of the quarter.

3.     The unaudited financial results for the quarter ended June 30, 2013 have been reviewed by the Audit Committee of the Board and approved by the Board of Directors of the Company at its meeting held on August 1, 2013. The Limited Review for the unaudited financial results for the quarter ended June 30, 2013, as required under Clause 41 of the Listing Agreement has been completed by the statutory auditors.

4.     Figures for the previous period have been regrouped/reclassified wherever necessary, to conform to the current period's classification.

 

 

CONTINGENT LIABILITIES:

 

Particulars

31.12.2012

(Rs. In Millions)

31.12.2011

(Rs. In Millions)

Contingent Liabilities not provided for:

 

 

a) Direct tax

2837.896

1599.233

b) Indirect taxes - net of tax impact Rs. 4.255 Millions (Previous Year Rs. 3.693 Millions)

8.859

7.690

 

Notes:

 

The amounts shown above represent the best possible estimates of pending litigations/disputes arrived at on the basis of available information. The above do not include potential risks/demands, if any for ongoing issues, where no claims have been made against the company. The uncertainties and possible reimbursements if any are dependent on the outcome of the different legal processes which have been invoked by the Company or the claimants as the case may be and therefore cannot be predicted accurately. The Company engages reputed professional advisors to protect its interests and has been advised that it has strong legal positions against such disputes.

 


FIXED ASSETS:

 

Tangible Assets

­  Land (Freehold)

­  Buildings

­  Plant and Equipment

­  Information Technology Equipment

­  Furniture and Fixtures

­  Office Equipment

­  Vehicles

­  Leasehold Improvements

 

Intangible Assets

­  Patents and Trade Marks

 

 

PRESS RELEASES

 

NAINA DARPAN AND DISHADDRA PODDAR FROM NEW DELHI TO COMPETE IN HORLICKS WIZKIDS SOUTH ASIA FINALS 2013

 

May the best Wizkids make it to the Final Horlicks WizTeam!

 

New Delhi, Aug 3, 2013: The most sought after inter-school cultural and literary competition of the year- Horlicks Wizkids by Krayon is back with a bang. Horlicks Wizkids - the largest interschool fiesta running across India, Nepal, Pakistan and Sri Lanka, is now bigger and better. With the Chennai finals culminating with much fanfare, Naina Darpan, ASN Senior Sec School and Dishaddra Poddar, Ryan International, Mayur Vihar, emerged as the winners who will represent their city at the Horlicks Wizkids South Asia Finals in November 2013. The winners of Horlicks Wizkids South Asia 2013 winners will earn scholarships worth Rs 10000.000 Millions and a 5 day educational trip to Germany

 

The city finals round in New Delhi witnessed an overwhelming response from schools and children across the city with over 2000 students from more than 40 schools participating. The Airforce Auditorium was packed with students cheering for their teams showcasing their talents on the stage.

 

With Horlicks Wizkids in its 11th year, this unique competition is now a part of the co-scholastic curriculum prescribed by the National Curriculum Framework 2005 and is graded in every students’ school performance. It is one of the most sought after student engagement experience bringing all the students from various schools of a city under one roof, thus enhancing their social interaction and cooperation skills as well.

 

Commenting on the kick-off this year, Jayant Singh, EVP, Marketing, GlaxoSmithKline Consumer Healthcare India said, “Horlicks as a nourisher and nurturer aims to strive for an all-round growth and development for children. Taking the same proposition forward, with Horlicks Wizkids we hope to create avenues for students to display their aptitude that goes beyond academics and bring out the best in them!”

 

“The purpose of education is overall development of students; Wizkids is that platform that hones the personality of students making them more confident who understand their strengths. Over the year Wizkids has become an integral part of the school calendar in India and has given millions of students an opportunity to live their dreams,” Syed Sultan Ahmed, MD EduMedia, Project Director of Horlicks Wizkids added.

 

With more than 30 events in the field of arts, literature, painting, extra-curricular activities are being hosted by Krayon, Horlicks Wizkids is South Asia’s largest interschool fiesta for students from class 1 to 12. Students will be invited from all over India to take part in ‘Horlicks Wiz Team 2013’ through online registration or by visiting the closest host cities. Along with this Horlicks Wizkids also has an online competition Iwiz running on Facebook. This year some other new elements are live updates and online competitions on Twitter. Pinterest will also be used for photo trending purposes. A dedicated YouTube channel is created to host all the videos from Horlicks Wizkids. In addition to the existing competition, a unique feature of Horlicks Wizkids this year will be the Shadow Campaign which invites students from non-host cities to be a part of the competition and get a chance to present their talent.

 

 

GURGAON, NCR INDIA, AUGUST 1, 2013

 

GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED HIGH GROWTH FOR THE QUARTER ENDED JUNE 30, 2013

 

·         Sales up by 17 %

·         Net Profits up by 12.5 %

·         Net Profits up by 12.5 %

 

Overview

 

GlaxoSmithKline Consumer Healthcare Limited (GSKCH) today declared its financial results for the quarter ended June 30, 2013. Net sales at Rs 8530.000 Millions recorded a growth of 17 % over 2012 with PBT at Rs. 1820.000 Millions growing by 15 % for the same period and PAT at Rs 1200.000 Millions growing by 12.5 %.

 

Commenting on the Company’s performance, Mr. Zubair Ahmed, MD, GSKCH India, said, “GSKCH has been recording robust growth year-on-year across portfolios. Over the last few months, we have been focusing not only on base products but also high science based value-added products, which are designed to address specific needs of the consumer. These specialised products are the next level of offering for consumers who are looking at focused benefits for their family. Products such as Women’s Horlicks, Mother’s Horlicks, Horlicks ProMind and Horlicks Nutribic, have contributed to the Company’s growth. In addition, we have also been concentrating on driving deeper penetration across categories which has also contributed to the overall growth of the brands. Furthermore, cost-efficient engineering programmes have helped the Company deliver progressive result. “

 

India Performance

 

Another quarter of strong double digit profitable growth was driven by superior Sales performance and a strong cost management programme.

 

GSKCH is committed to top line growth and has been exceeding expectations over the last quarters by remarkably maintaining its performance.

 

Highlights

 

The GSK health drink portfolio continues to be a market leader with an overall volume share of 65.2% (MAT Jun 2013).

 

In May this year, Horlicks has made entry into the flavoured oats segment with the launch of three new exciting flavours (Classic Masala, Southern Spices and Mild Kurma).

 

Portfolio expansion with the launch of Nutribic Honey and Crispy Oats biscuits in April’13.

 

Backed by a strong marketing and activation package, the Boost volume market share has climbed to 28.3% from 27.4% in its strong market of South (MAT Jun 2013, South U+R).

 

Boost launched a new campaign in April’13-‘Boost powering Sachin’s Stamina’. The new campaign was accompanied with a packaging disruption with Sachin’s graphical image on base packs.

 

Oral Health Care and Wellness

 

Increased focus on Oral Healthcare (OHC) category in India through launch of Sensodyne Repair and Protect, in April ’13.

 

Over The Counter (OTC) portfolio extension of brand Eno into the liquid and tablet format in June ’13. The brand also launched a new flavour- Nimbu Shikanji in its powder format.

 

About GlaxoSmithKline Consumer Healthcare Limited

 

GSKCH is an associate of GlaxoSmithKline Plc. of U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is the largest player in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 3450 people.

 

GSKCH has a strong marketing and distribution network in India comprising over 650 distributors and a direct coverage of over 750000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent names such as Eno, Crocin and Iodex as well as products from the global portfolio like and Sensodyne.


 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                           None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.92

UK Pound

1

Rs. 99.45

Euro

1

Rs. 83.92

 

 

INFORMATION DETAILS

 

Information Gathered by :

PLK

 

 

Report Prepared by :

BVA

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

7

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

7

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTERS 

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

64

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.